{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:38:56Z","timestamp":1792805936222,"version":"4.5.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide and a leading cause of end-stage kidney disease, yet disease-specific therapeutic options remain limited. Emerging evidence implicates gut microbiota dysbiosis and innate immune activation, particularly NLRP3 (NOD-, LRR- and pyrin domain-containing protein 3) inflammasome-related signaling, in IgAN pathogenesis. However, whether human umbilical cord mesenchymal stem cell\u2013derived exosomes (hUCMSC-Exos) are associated with changes in renal injury and gut\u2013immune-related parameters in IgAN remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      hUCMSC-Exos were isolated and administered to an IgAN-like mouse model. Renal function, histopathological changes, and systemic inflammatory markers were assessed. Gut microbiota composition was analyzed using 16S rRNA sequencing, and exploratory microbial co-occurrence networks were constructed.\n                      <jats:italic>In vitro<\/jats:italic>\n                      , podocytes stimulated with galactose-deficient IgA1 (Gd-IgA1) were used to evaluate inflammasome-related markers following exosome exposure. Transcriptomic data from human IgAN glomeruli (GSE93798) were analyzed to explore inflammatory and immune-related gene signatures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      hUCMSC-Exos were associated with changes in renal injury markers in IgAN-like mice, along with alterations in gut microbial composition. Microbiome analysis showed a shift toward a microbial profile closer to controls, with enrichment of bacterial taxa previously reported in association with gut metabolic homeostasis in other cohorts, including Anaerostipes, Dorea, and Ruminococcus. These taxa showed correlations with renal dysfunction indicators and inflammatory markers and were identified as hub taxa in an exploratory co-occurrence network. Transcriptomic analysis of human IgAN glomeruli revealed altered expression of NLRP3 inflammasome-related genes and aryl hydrocarbon receptor (AhR)-related signaling components, suggesting context-dependent inflammatory activity requiring further validation.\n                      <jats:italic>In vitro<\/jats:italic>\n                      , hUCMSC-Exos were associated with reduced levels of NLRP3, IL-1\u03b2, and IL-18 in Gd-IgA1\u2013stimulated podocytes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>hUCMSC-Exos were associated with changes in renal injury markers in an IgAN-like model, accompanied by alterations in gut microbiota composition and inflammasome-related inflammatory markers. These findings are consistent with a potential association between gut microbiota, innate immune-related signaling, and renal injury in IgAN. hUCMSC-Exos may represent a cell-free candidate for further investigation in IgAN. However, these observations are descriptive and associative in nature, and causal mechanisms cannot be inferred from the present study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1854005","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:18:35Z","timestamp":1780287515000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Human umbilical cord mesenchymal stem cell\u2013derived exosomes are associated with changes in renal injury markers, gut microbiota composition, and inflammatory signaling in IgA nephropathy"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuanyuan","family":"He","sequence":"first","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Zunyi Medical University","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Zunyi Medical University","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Zunyi Medical University","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Zunyi Medical University","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Laboratory Animal Centers, Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengzhi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Guizhou Moutai Hospital","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengxia","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Zunyi Medical University","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.07420716","article-title":"IgA nephropathy","volume":"12","author":"Rodrigues","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41581-024-00885-3","article-title":"The pathogenesis of IgA nephropathy and implications for treatment","volume":"21","author":"Cheung","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1436923","article-title":"Contemporary review of IgA nephropathy","volume":"15","author":"Filippone","year":"2024","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-023-01874-8","article-title":"Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis","volume":"37","author":"Vaz de Castro","year":"2024","journal-title":"J Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2018.05.020","article-title":"The gut-renal connection in IgA nephropathy","volume":"38","author":"Coppo","year":"2018","journal-title":"Semin Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00467-017-3652-1","article-title":"The gut-kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition","volume":"33","author":"Coppo","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae274","article-title":"The gut microbiome as a potential therapeutic target in IgA nephropathy","volume":"40","author":"Pereira","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12882-024-03646-3","article-title":"Advancements in understanding the role of intestinal dysbacteriosis mediated mucosal immunity in IgA nephropathy","volume":"25","author":"Fan","year":"2024","journal-title":"BMC Nephrol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103835","article-title":"New thoughts on the intestinal microbiome-B cell-IgA axis and therapies in IgA nephropathy","volume":"24","author":"Dang","year":"2025","journal-title":"Autoimmun Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107085","article-title":"Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population","volume":"89","author":"Zhong","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B11","article-title":"Correlation of gut microbiota and metabolic imbalances with tryptophan metabolism, AhR, and NLRP3 inflammasome in peripheral blood of IgA nephropathy patients [In Chinese","volume":"48","author":"Yu","year":"2025","journal-title":"J Zunyi Med Univ"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1438683","article-title":"Characteristics, pathogenic and therapeutic role of gut microbiota in immunoglobulin A nephropathy","volume":"16","author":"Yao","year":"2025","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/mog.0000000000000789","article-title":"Role of gut-kidney axis in renal diseases and IgA nephropathy","volume":"37","author":"Monteiro","year":"2021","journal-title":"Curr Opin Gastroenterol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12882-021-02414-x","article-title":"Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy","volume":"22","author":"Chai","year":"2021","journal-title":"BMC Nephrol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1171517","article-title":"Causal effects between gut microbiota and IgA nephropathy: a bidirectional Mendelian randomization study","volume":"13","author":"Ren","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1124\/pr.114.009001","article-title":"The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology","volume":"67","author":"Esser","year":"2015","journal-title":"Pharmacol Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1090261","article-title":"Naringenin protects against acute pancreatitis-associated intestinal injury by inhibiting NLRP3 inflammasome-related responses via AhR signaling","volume":"14","author":"Yan","year":"2023","journal-title":"Front Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1421346","article-title":"Aryl hydrocarbon receptor: current perspectives on key signaling partners and immunoregulatory role in inflammatory diseases","volume":"15","author":"Bahman","year":"2024","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.tips.2020.11.006","article-title":"Tryptophan metabolism as a pharmacological target","volume":"42","author":"Modoux","year":"2021","journal-title":"Trends Pharmacol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s44321-024-00135-w","article-title":"The influence of AhR on immune and tissue biology","volume":"16","author":"Stockinger","year":"2024","journal-title":"EMBO Mol Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126596","article-title":"Mesenchymal stem cell-derived extracellular vesicles to the rescue of renal injury","volume":"22","author":"Birtwistle","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2024.2381597","article-title":"Mesenchymal stem cell-derived exosomes ameliorate diabetic kidney disease through NOD2 signaling pathway","volume":"46","author":"Wang","year":"2024","journal-title":"Ren Fail"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116672","article-title":"Therapeutic potential: The role of mesenchymal stem cells from diverse sources and their derived exosomes in diabetic nephropathy","volume":"175","author":"Liu","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119750","article-title":"Urinary exosomal mRNAs as biomarkers for predicting the therapeutic effect of renin-angiotensin system inhibitors in IgA nephropathy patients","volume":"561","author":"Zhao","year":"2024","journal-title":"Clin Chim Acta"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2024.2319326","article-title":"Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy","volume":"46","author":"Zhang","year":"2024","journal-title":"Ren Fail"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.5c00523","article-title":"Podocyte proteomics revealed hUCMSC-exosomes ameliorate diabetic kidney disease through inhibiting Talin-1 mediated EMT","volume":"24","author":"Zhang","year":"2025","journal-title":"J Proteome Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-024-02027-0","article-title":"Exosomes from human umbilical cord stem cells suppress macrophage-to-myofibroblast transition, alleviating renal fibrosis","volume":"47","author":"Guo","year":"2024","journal-title":"Inflammation"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"B30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.25259\/ijn_425_23","article-title":"IgA nephropathy: Emerging potential mechanisms of disease","volume":"34","author":"Roberts","year":"2024","journal-title":"Indian J Nephrol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.06.023","article-title":"Galectin-3 contributes to pathogenesis of IgA nephropathy","volume":"106","author":"Chou","year":"2024","journal-title":"Kidney Int"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/stmcls\/sxad010","article-title":"Mesenchymal stem cell-derived exosomes ameliorate diabetic kidney disease through the NLRP3 signaling pathway","volume":"41","author":"Wang","year":"2023","journal-title":"Stem Cells"},{"key":"B33","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41419-022-05179-9","article-title":"CD36 aggravates podocyte injury by activating NLRP3 inflammasome and inhibiting autophagy in lupus nephritis","volume":"13","author":"Lv","year":"2022","journal-title":"Cell Death Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12967-022-03585-3","article-title":"Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling","volume":"20","author":"Tan","year":"2022","journal-title":"J Transl Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.557368","article-title":"A comparative study of the gut microbiota associated with immunoglobulin a nephropathy and membranous nephropathy","volume":"10","author":"Dong","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s11658-025-00716-8","article-title":"Exploring the role of gut microbiota modulation in the long-term therapeutic benefits of early MSC transplantation in MRL\/lpr mice","volume":"30","author":"Pan","year":"2025","journal-title":"Cell Mol Biol Lett"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.01.044","article-title":"Autophagy activation within inflammatory microenvironment improved the therapeutic effect of MSC-derived extracellular vesicle in SLE","volume":"77","author":"Liao","year":"2025","journal-title":"J Adv Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.aninu.2024.05.001","article-title":"Double-side role of short chain fatty acids on host health via the gut-organ axes","volume":"18","author":"Gao","year":"2024","journal-title":"Anim Nutr"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/nu17172904","article-title":"Gut microbiome-derived short-chain fatty acids in glomerular protection and modulation of chronic kidney disease progression","volume":"17","author":"Szrejder","year":"2025","journal-title":"Nutrients"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/nu17050772","article-title":"Beneficial effects of butyrate on kidney disease","volume":"17","author":"Diep","year":"2025","journal-title":"Nutrients"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17924","article-title":"Epigenetic histone modification by butyrate downregulates KIT and attenuates mast cell function","volume":"27","author":"Gudneppanavar","year":"2023","journal-title":"J Cell Mol Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/febs.17005","article-title":"Butyrate functions as a histone deacetylase inhibitor to protect pancreatic beta cells from IL-1\u03b2-induced dysfunction","volume":"291","author":"Pedersen","year":"2024","journal-title":"FEBS J"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae118","article-title":"Propionate and butyrate counteract renal damage and progression to chronic kidney disease","volume":"40","author":"Corte-Iglesias","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1781013","article-title":"Integrated multi-omics analysis unveils microbiota-metabolite-host interactions and novel biomarkers for early diabetic kidney disease diagnosis","volume":"17","author":"Jiang","year":"2026","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1854005\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:18:37Z","timestamp":1780287517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1854005\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2026.1854005"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1854005","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"article-number":"1854005"}}